Previous Article | Next Article 
Journal of Virology, June 2000, p. 5101-5107, Vol. 74, No. 11
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Single Amino Acid Change in the Newcastle Disease
Virus Fusion Protein Alters the Requirement for HN Protein in
Fusion
Theresa A.
Sergel,
Lori W.
McGinnes, and
Trudy G.
Morrison*
Department of Molecular Genetics and
Microbiology, University of Massachusetts Medical School,
Worcester, Massachusetts 01655
Received 30 September 1999/Accepted 3 March 2000
 |
ABSTRACT |
The role of a leucine heptad repeat motif between amino acids 268 and 289 in the structure and function of the Newcastle disease virus
(NDV) F protein was explored by introducing single point mutations into
the F gene cDNA. The mutations affected either folding of the protein
or the fusion activity of the protein. Two mutations, L275A and L282A,
likely interfered with folding of the molecule since these proteins
were not proteolytically cleaved, were minimally expressed at the cell
surface, and formed aggregates. L268A mutant protein was cleaved and
expressed at the cell surface although the protein migrated slightly
slower than wild type on polyacrylamide gels, suggesting an alteration in conformation or processing. L268A protein was fusion inactive in the
presence or absence of HN protein expression. Mutant L289A protein was
expressed at the cell surface and proteolytically cleaved at better
than wild-type levels. Most importantly, this protein mediated
syncytium formation in the absence of HN protein expression although HN
protein enhanced fusion activity. These results show that a single
amino acid change in the F1 portion of the NDV F protein
can alter the stringent requirement for HN protein expression in
syncytium formation.
 |
INTRODUCTION |
Enveloped viruses initiate infection
with attachment to susceptible cells and subsequent membrane fusion,
processes directed by the viral glycoproteins. Membrane fusion mediated
by most paramyxoviruses, such as Newcastle disease virus (NDV),
requires two virion-associated glycoproteins, the attachment protein or
hemagglutinin-neuraminidase (HN) protein and the fusion (F) protein
(reviewed in reference 13). The F protein is
directly involved in membrane fusion, although in most systems, the HN
protein has an undefined role in this step of infection that can be
genetically separated from its attachment activity (25, 26).
However, the simian virus 5 (SV5) and respiratory syncytial virus (RSV)
attachment proteins are not absolutely required for fusion mediated by
the F protein of these viruses (1, 8, 12). The reason for
these different requirements for attachment proteins in fusion is not clear.
Paramyxovirus F protein is synthesized as an inactive precursor,
F0, which must be proteolytically cleaved to form a
disulfide-linked heterodimer of F1 and F2 in
order to direct membrane fusion (14). The F protein has
several domains that are involved in fusion. The amino terminus of
F1, termed the fusion peptide or fusion sequence, is
thought to insert into the target membrane (7). In addition,
two heptad repeat (HR) regions in the F1 polypeptide have
been identified as important to fusion. One, HR1, is located just
carboxyl terminal to the fusion peptide (4); the other, HR2,
is located adjacent to the transmembrane domain (3). The HR2
domain has a leucine zipper motif. The importance of these domains for
fusion has been shown by mutational analysis (2, 24, 27). In
addition, peptides with sequences from either of these domains inhibit
fusion (15, 23, 31-33), possibly because they mimic the
respective domains in the intact protein and interfere with
conformational changes in the molecule necessary for fusion. Indeed, it
has been shown in three different paramyxovirus systems that peptides
with sequences from the HR1 and HR2 domains form a complex which may
mimic the interaction of these two domains during activation of the F
protein (6, 11, 34).
Ghosh et al. (5) have recently noted that paramyxovirus F
protein sequences contain a second leucine zipper-like motif located
between HR1 and HR2. They suggested that this domain was important for
fusion since a peptide with sequence from this region of the Sendai
virus (SV) F protein inhibited hemolysis mediated by virions.
Furthermore, they reported that this peptide formed complexes with
peptides derived from the HR1 and HR2 domains of SV. These findings
implicate this third domain in the activity of the F protein. Indeed,
the NDV F protein has this leucine repeat motif which extends for four
heptads. To explore the role of this domain in the NDV F protein
maturation and fusion activity, we mutated each of the leucine residues
in the motif. We report that single amino acid changes in this motif
affect either folding of the molecule or the fusion activity as
measured by syncytium formation. One alteration enhances the fusion
activity of the protein in the presence of the HN protein.
Surprisingly, this mutation also allows the NDV F protein to direct
fusion in the absence of the HN protein. These results represent the
first report of NDV syncytium formation in the absence of HN protein
expression and suggest that this region of the F protein may play a
role in determining the requirement of attachment protein in NDV fusion.
 |
MATERIALS AND METHODS |
Cells, vectors, and viruses.
Cos-7 cells, obtained from the
American Type Culture Collection, were maintained in Dulbecco modified
Eagle medium supplemented with nonessential amino acids, vitamins,
penicillin-streptomycin, and 10% fetal calf serum.
NDV HN and F genes (derived from strain AV), characterized previously
(26), were expressed in Cos cells by using pSVL, obtained from Pharmacia. Viral genes were inserted into SacI- and
XbaI-cut plasmid DNA.
Site-specific mutagenesis.
Mutations in the F gene were
generated using a Chameleon double-stranded site-specific mutagenesis
kit from Stratagene. The appropriate oligomer, at least 30 nucleotides
in length, was used for each mutation. The entire gene of the mutant
DNA was sequenced to verify that the rest of the gene remained
unchanged by the mutagenesis reaction. The mutations isolated are shown
in Fig. 1B. Mutants are named with the
amino acid, in single-letter code, in the wild type, the position of
the amino acid change, and the amino acid in the mutant.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Locations of HR3 mutations. (A) Linear representation of
the sequence of the NDV fusion protein, with important domains
indicated. HR3 is located from amino acids 268 to 289. (B) Amino acid
sequence of HR3 in the NDV F1 protein from amino acids 265 to 296. The mutated leucine residues are indicated in bold.
|
|
Transfections.
Cos cells were plated at 2 × 105 per 35-mm-diameter plate and transfected 20 to 24 h later. Transfections were accomplished using Lipofectamine
(BRL/Gibco). For each 35-mm-diameter plate, a mix of 0.1 µg of DNA in
0.1 ml of OptiMEM (BRL/Gibco) and 10 µl of transfection reagent in
0.1 ml of OptiMEM was incubated at room temperature for 45 min, diluted
with 0.7 ml of OptiMEM, and added to a plate previously washed with
OptiMEM. Cells were incubated with the transfection reagent-DNA
complexes for 5 to 6 h, and then 2 ml of complete Cos cell medium
was added.
Antibodies.
Antibodies used for detection of the fusion or
HN protein were anti-Fu1a, anti-Ftail, anti-H antibody, and anti-NDV
antibody. Anti-Fu1a, an F protein monoclonal antibody, was previously
described (18) and obtained from Mark Peeples. Anti-Ftail
was raised against a synthetic peptide with the sequence of the
cytoplasmic tail of the fusion protein as described by Wang et al.
(30) and prepared by the Peptide Core Facility of the
University of Massachusetts Medical School. Antibody used to detect HN
protein was anti-H, a polyclonal rabbit antibody raised against the
carboxyl-terminal domain of the HN protein expressed in
Escherichia coli as a TrpE fusion as previously described
(26). Anti-NDV is a polyclonal antiserum raised in rabbits
against UV-inactivated virions as previously described (16).
This antiserum contains antibodies against both HN and F proteins.
Immunofluorescence.
Cos cells were plated on 35-mm-diameter
plates containing glass coverslips and transfected as described above.
The cells were washed twice with phosphate-buffered saline (PBS)
containing 1.5% bovine serum albumin (BSA) and 0.02% azide and
incubated at 4°C in PBS containing 3% BSA, 0.02% sodium azide, and
antibody (diluted 1:100) for 1 h. Cells were washed three times
with ice-cold PBS containing BSA and azide and incubated on ice with
PBS containing BSA, azide, and Alexa dye (Alexa 488)-conjugated
anti-rabbit immunoglobulin G (IgG) or Alexa dye (Alexa 568)-conjugated
anti-mouse IgG (Molecular Probes) for 1 h. Cells were washed with
cold PBS containing BSA and azide and visualized in a Nikon
fluorescence microscope using the appropriate filters. Photographs were
taken using Kodak ASA 3200 film.
Western analysis of mutant proteins.
Cell extracts were
diluted in sample buffer and loaded onto 10% polyacrylamide gels
without boiling. After electrophoresis, the gels were equilibrated in
transfer buffer (25 mM Tris, 190 mM glycine, 5% methanol [pH 8.2])
and transferred to Immobilon-P (Millipore Corp.) membranes. The
membrane was blocked in PBS containing 0.5% Tween 20 and 10% nonfat
dried milk overnight at 4°C. Membranes were washed in PBS-Tween 20 and incubated with primary antibody diluted in PBS-Tween 20-0.5%
nonfat milk for 2 h at room temperature. Membranes were washed in
PBS-Tween 20 and then incubated for 1 h at room temperature in
secondary antibody, anti-rabbit IgG coupled to horseradish peroxidase
(Boehringer Mannheim) diluted in PBS-Tween 20-0.5% nonfat milk.
Membranes were washed extensively, and bound antibody was detected
using the ECL (enhanced chemiluminescence) Western blotting detection
reagent system (Amersham).
Radiolabeling and immunoprecipitation of protein.
Transfected cells were radiolabeled for 2 h at 37°C in Dulbecco
modified Eagle medium lacking methionine but containing 100 mCi of
[35S]methionine (Amersham) per ml and then chased for
12 h in nonradioactive complete medium. At the end of the labeling
period, cells were washed in PBS and lysed in reticulocyte standard
buffer (0.01 M Tris-HCl [pH 7.4], 0.01 M NaCl) containing 1% Triton
X-100, 0.5% sodium deoxycholate, and 2 mg of iodoacetamide per ml.
Nuclei were removed by centrifugation. Immunoprecipitation of NDV
proteins was accomplished as previously described (16).
Fusion assays.
Cos cells were transfected with wild-type or
mutant F protein genes or cotransfected with the wild-type HN protein
gene. At 24 and 48 h posttransfection, the nuclei in 40 fusion
areas were counted to determine the average size of syncytia at each
time point as previously described (26). Values obtained
after transfection of the vector alone were subtracted.
 |
RESULTS |
Synthesis, stability, and processing of mutant
proteins.
A leucine repeat motif, first noted by Ghosh et al.
(5) in the SV F protein sequence, is located between HR1 and
HR2 at amino acids 268 to 296 (Fig. 1A) in the NDV F protein sequence. Because this sequence represents the third heptad repeat motif characterized in the NDV F protein sequence, it is labeled HR3 in Fig.
1. The amino acid sequence in this region of the F protein is shown in
Fig. 1B, with the leucine residues in the repeat motif shown in bold.
Each of these residues was changed to alanine individually to generate
four mutants, L268A, L275A, L282A, and L289A.
To characterize the synthesis and processing of each mutant protein, F
proteins were immunoprecipitated from radioactively labeled Cos-7 cells
transfected with each mutant cDNA. The proteins present in the
immunoprecipitate are shown in Fig. 2. In
the absence of reducing agent (Fig. 2A), cleaved as well as the
disulfide-linked cleaved fusion protein comigrated with an approximate
molecular mass of 66 kDa. As previously reported, wild-type F protein
preparations also contained small amounts of a higher-molecular-weight
form (24, 27). Expression of L289A mutant DNA resulted in
both monomer and oligomer forms of the protein which comigrated with the wild-type protein and which were expressed at levels comparable to
wild-type levels. L268A mutant protein was also present in amounts
roughly comparable to those of wild-type protein. However, both the
monomer and oligomeric forms of the protein migrated slightly slower
than the wild-type forms of the protein. Only small amounts of L275A
and L282A mutant proteins entered the gel, although densitometer
analysis showed that there was more radioactively labeled material at
the top of the gel and in the stacking gel than in other lanes.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoprecipitation of radioactively labeled mutant F
proteins. Cos cells transfected with pSVL-F DNA as well as each of the
four HR3 mutants, L268A, L275A, L282A, and L289A, were radioactively
labeled with 35S as described in Materials and Methods.
Proteins present in lysates from equivalent numbers of cells were
immunoprecipitated with anti-Ftail, and the precipitated protein was
electrophoresed in the absence (A) or presence (B) of reducing agent.
Lane 1, vector (V) alone; lane 2, wild-type (WT) F; lane 3, L268A; lane
4, L275A; lane 5, L282A; lane 6, L289A. Fnr, nonreduced
fusion protein; F0, uncleaved fusion protein;
F1, cleaved form of the fusion protein. The arrowhead
indicates SDS-resistant F protein species.
|
|
When the precipitated fusion proteins were electrophoresed in the
presence of reducing agent, wild-type F0 and the cleaved form, F1, were resolved. L289A protein was clearly cleaved
at least as efficiently as wild-type F protein. L268A protein was also
cleaved. Furthermore, the L268A F1 migrated slightly slower than wild-type F1, while the uncleaved form of the protein
comigrated with wild-type F0. This result suggested that
either the conformation, cleavage, or, more likely, the oligosaccharide
processing of the F1 protein was abnormal. Interestingly,
in contrast to results shown in Fig. 2A, under reducing conditions, the
monomeric forms of L275A and L282A F0 proteins were
resolved but no F1 was seen, suggesting that these proteins
were not cleaved. Furthermore, these results suggested that these two
mutant proteins form large sodium dodecyl sulfate (SDS)-resistant
aggregates which did not enter the gel in the absence of reducing agent.
To assess the relative steady-state levels of these proteins in
transfected cells and to characterize SDS-resistant species formed by
these mutant proteins, the proteins were detected by Western analysis
(Fig. 3). Because NDV F protein is not
well detected by Western analysis after boiling of the protein
(27), samples were incubated in sample buffer at 50°C. In
the absence or presence of reducing agent, material reactive to the F
antibody could be detected at levels comparable to wild-type levels,
suggesting that these proteins were relatively stable in transfected
cells. However, the forms of the protein seen in the absence of boiling were quite different from wild-type forms, suggesting conformational differences in the mutant proteins. In the absence of reducing agent,
all mutant proteins formed large complexes that electrophoresed at the
top of the gel or in the stacking buffer. In the presence of reducing
agent, a fraction of L268A, L275A, and L282A mutant proteins resolved
as monomeric forms, although only monomeric F0 was resolved
for the three mutants, a result again suggesting that these mutant
proteins were not efficiently cleaved to F1 and
F2. However, the F289A mutant protein contained very little monomeric material. Thus, while F289A mutant protein appeared to be
cleaved as shown in Fig. 2, it may exist in conformational forms
somewhat different from wild-type forms.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
SDS-resistant conformational forms of the F protein
detected by Western analysis. Cos cells were transfected with wild-type
and mutant F protein DNAs for 48 h as described in legend to Fig.
2. Proteins present in the resulting cell lysates were electrophoresed
in the absence (A) or presence (B) of reducing agent. Proteins in
sample buffer were incubated at 50°C for 5 min prior to loading onto
the gel. Anti-Ftail was used to bind F protein in the blot. Lane 1, vector (v) alone; lane 2, wild-type (wt) F; lane 3, L268A; lane 4, L275A; lane 5, L282A; lane 6, L289A. Fnr, nonreduced fusion
protein; F0, uncleaved fusion protein; F1,
cleaved form of the fusion protein. Arrowheads on each side indicate
SDS-resistant F protein species.
|
|
Surface expression of mutant proteins in the absence of HN
protein.
Immunofluorescence detection of F protein on the surfaces
of intact cells transfected mutant F protein genes was used to
determine if the mutant proteins were expressed at cell surfaces. Shown in Fig. 4A, is the fluorescence observed
on cells expressing wild-type F protein. The mutant L268A was detected
at the surface, although the signal was much less intense than for
wild-type protein (Fig. 4B). L275A (Fig. 4C) was minimally detected at
the cell surface, while L282A was undetectable (Fig. 4D). Significant
levels of the L289A mutant protein were detected at the surfaces of
transfected cells (Fig. 4E). Surprisingly, these L289A-expressing cells
formed syncytia. Furthermore, the vast majority of L289A-expressing
cells were in syncytia.

View larger version (97K):
[in this window]
[in a new window]
|
FIG. 4.
Surface expression of mutant proteins detected by
immunofluorescence. Intact confluent monolayers of Cos cells growing on
coverslips and transfected with wild-type (A) or mutant F protein cDNAs
were incubated with anti-NDV antisera and then with
fluorescence-labeled goat anti-rabbit antisera as described in
Materials and Methods. (B) L268A protein; (C) L275A protein; (D) L282A
protein; (E) L289A protein. All fields shown were exposed for 2 s
using a 25× objective.
|
|
Surface expression of these mutants was quantitated by surface
immunoprecipitation as previously described (16, 27). Cells transfected with wild-type and mutant proteins were subjected to a
radioactive label followed by a 12-h chase to minimize differences due
to different kinetics of intracellular transport. These cells were
incubated with anti-NDV antibody, and complexes formed were resolved on
polyacrylamide gels as shown in Fig. 5.
Interestingly, L268A and L289A proteins detected at the surface were
cleaved much more efficiently than wild-type protein. The small amount of L275A protein detected was uncleaved, consistent with results shown
in Fig. 2 and 3.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Quantitation of surface expression of mutant proteins.
Cells transfected with wild-type and mutant F protein DNAs for 30 h were labeled with [35S]methionine for 2 h and then
incubated in complete medium for 12 h. Cells were incubated with
anti-NDV antibody on ice as previously described, unbound antibody was
removed, and immune complexes in cell lysates were electrophoresed in
polyacrylamide gels. The resulting autoradiograph was scanned with a
microdensitometer, and the amount of radioactively labeled protein
present in each lane, relative to the wild-type (wt) level, which is
set at 100%, is shown at the bottom. V, vector, F0,
uncleaved fusion protein; F1, cleaved form of the fusion
protein; Marker, infected cell lysate; NP, nucleocapsid protein.
|
|
Fusion activity of mutant proteins in the presence and absence of
HN protein expression.
Syncytium formation after L289A
transfection shown in Fig. 4 suggested that this mutant protein could
direct fusion in the absence of HN protein expression. To measure the
fusion activity of this mutant protein as well as the other three
mutant proteins, syncytium formation in the presence and absence of HN
protein expression was quantitated as previously described by
determining syncytium size (Fig. 6).
Mutants L268A, L275A, and L282A had no fusion activity in the presence
or absence of HN protein expression. However, L289A mutant protein in
the absence of HN protein clearly directed syncytium formation nearly
as well as the wild-type F protein in the presence of HN protein.
Interestingly, the expression of HN protein enhanced fusion directed by
L289A protein, significantly increasing syncytium size over that
observed with wild-type F protein and HN protein expression.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Fusion activity of mutant proteins in the presence and
absence of HN protein expression. Sizes of syncytia formed in
monolayers of Cos cells transfected with wild-type (wtF) or mutant F
protein cDNAs in the presence or absence of HN protein cDNA were
determined as described in Materials and Methods. The results are the
average of three different experiments.
|
|
These results were visualized and confirmed by immunofluorescence
detection of syncytia formed in the presence and absence of HN protein
expression (Fig. 7). Monolayers of cells
expressing L289A only (Fig. 7E) contained syncytia which were somewhat
smaller than those found in monolayers of cells expressing both
wild-type F and HN proteins (Fig. 7A and B). Coexpression of both L289A and wild-type HN proteins (Fig. 7C and D) resulted in syncytia which
were considerably larger than those seen after coexpression of
wild-type F and HN.


View larger version (8455K):
[in this window]
[in a new window]
|
FIG. 7.
Immunofluorescence of syncytia formed by mutant L289A in
the presence and absence of HN protein expression. Intact, confluent
monolayers of Cos cells growing on coverslips and transfected with
wild-type F protein cDNA or L289A mutant cDNA and pSVL-HN DNA were
incubated with anti-Fu1a monoclonal antibody (specific for F) and
anti-H antisera (specific for HN) and then with goat anti-rabbit
antisera coupled to Alexa 568 and goat anti-mouse antisera coupled to
Alexa 488 as described in Materials and Methods. The left panels show
cells photographed with filters designed to detect Alexa 488 (HN
protein). Fields A (HN plus wild-type F) and C (HN plus L289A) were
exposed for 2 s to ASA 3200 film. The right panels show cells
photographed with filters designed to detect Alexa 568 (F protein).
Panel B (HN plus wild-type F) was exposed for 25 s, panel D (HN
plus L289A) was exposed for 20 s, and panel E (L289A) was exposed
for 10 s. All panels were photographed with a 25× objective.
|
|
 |
DISCUSSION |
The report that a peptide, consisting of amino acids 269 to 307 in
the SV F protein, inhibited fusion as measured by hemolysis implicated
this region of the SV F protein in the fusion activity of the
protein (5). This SV F protein sequence contains a leucine repeat motif in which a leucine residue is present every seven residues
for a span of 28 amino acids. Such heptad repeat sequences are often
found in
-helical structures that participate in intermolecular or
intramolecular coiled-coil interactions. Analysis of this sequence using several different secondary structure prediction programs predicted only short stretches of
helix within this region of the
SV F protein. However, this repeated leucine motif is conserved in
comparable regions in several paramyxovirus F protein sequences (5), suggesting that this region may have some importance in the structure or function of these proteins. To analyze the role of
this region in the structure and function of the NDV F protein, single-point mutations were introduced into the repeated leucine residues. Interestingly, mutations in this region affected either folding of the protein or the fusion activity of the protein.
Mutation of the two middle leucine residues, at positions 274 and 281, affected the folding of the molecule, and expression of these two
mutant proteins resulted in little to no detection of the molecules at
the cell surface. Mutation of the first leucine in the motif, at amino
acid 268, also resulted in a conformationally abnormal protein that was
nevertheless proteolytically cleaved and expressed at the cell surface,
although at a slightly lower level than the wild-type protein. This
mutant protein had no fusion activity in the presence of the HN
protein, a result that suggests that the HR3 region may be involved in
fusion activity in some way. However, the properties of the protein
mutated in the last leucine in this motif, at amino acid 289, indicate
even more clearly that this region is important in fusion.
In most paramyxovirus systems, expression of the HN protein as well as
F protein is strictly required for fusion (13). Indeed, wild-type NDV F protein shows no fusion activity in the absence of the
HN protein even at low frequency (26). There are, however, two exceptions to this observation. The SV5 F protein can direct fusion
in the absence of HN protein expression although the HN protein
enhances the fusion activity of the F protein (1, 8). Similarly, several reports indicate that the RSV F protein can mediate
fusion independent of expression of the attachment protein, G (12,
22). Since the structural determinants of the paramyxovirus F
protein are quite highly conserved across the family (17), it is not clear why the SV5 and RSV F proteins have requirements for
fusion different from those of other paramyxovirus F proteins. However,
the report of Ito et al. (10) that a single amino acid difference in the F2 polypeptide of SV5 can account for
different requirements for HN protein of different strains of SV5 may
indicate that conformational alterations affect the HN protein
requirement. Our results show that a single amino acid change in the
NDV F1 polypeptide results in an F protein, F-L289A, which
mediates fusion in the absence of HN protein expression. As in the SV5
system (1), coexpression of the HN protein significantly
enhances the fusion activity of F-L289A.
As noted by Ghosh et al. (5), the repeated leucine motif,
HR3, is conserved in several paramyxovirus F proteins. It was therefore
of interest to compare the HR3 sequences of SV5 and RSV F proteins with
other paramyxovirus F proteins to determine if variation in this region
could account for the different requirements for the HN protein. Figure
8 shows a comparison of the primary amino
acid sequence of the HR3 regions from a number paramyxovirus F
proteins. As noted by Ghosh et al. (5), the leucine repeat motif is found in F proteins of the paramyxoviruses SV, parainfluenza virus 1 (PIV1), and PIV3, as well as NDV. However, the sequences of the
SV5 and RSV F proteins do not have a leucine repeat motif in this
region.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 8.
Comparisons of sequences of HR3 regions in F proteins of
different paramyxoviruses. The leucine residues or hydrophobic residues
in the heptad repeat motif are in bold type. Amino acid positions are
indicated by numbers at the left. Two different sequences are shown for
RSV. MuV, mumps virus; MV, measles virus.
|
|
The absence of a leucine repeat in the HR3 region of a paramyxovirus F
protein does not, however, indicate that the F protein can mediate
fusion in the absence of HN protein. As shown in Fig. 8, the PIV4 and
PIV2 F proteins do not have this motif. In addition, the measles virus
and mumps virus F protein sequences have only two heptadic leucine
residues, although these sequences contain heptad repeats of
hydrophobic residues (L, V, I, or V) which extend for 35 amino acids.
All of these F proteins are reported to require the presence of HN for
fusion (9, 21, 28, 29). Thus, there is not an absolute
correlation between the presence of a leucine repeat motif and the
requirement for the attachment protein in fusion. Perhaps it is the
conformation of the domain or the interactions of this domain with
other protein domains rather than the leucine repeat motif per se that
is important for the HN protein requirement for fusion. Additional
mutational analysis of this region in several F proteins may clarify
the properties of this domain.
The results reported here as well as the properties of the SV5 and RSV
F proteins raise the question of the role of attachment in membrane
fusion (20). Based on the finding that syncytium formation
is inhibited after neuraminidase treatment of cells, which destroys the
receptor for HN protein, it has been argued that HN protein attachment
is required for membrane fusion in cells coexpressing the HN and F
proteins. However, syncytium formation by F proteins or mutant F
proteins in the absence of attachment protein clearly shows that
attachment mediated by the HN protein is not required in all
circumstances. Perhaps F proteins also have an attachment activity that
can function in these situations.
In summary, we report that a single amino acid change in the NDV F
protein sequence can alter the requirement for the HN protein expression in syncytium formation.
 |
ACKNOWLEDGMENTS |
This work was made possible by grants AI30572 and GM 37745 from
the National Institutes of Health.
We thank Mark Peeples for monoclonal antibody.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, University of Massachusetts
Medical School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-6592. Fax: (508) 856-1506. E-mail:
trudy.morrison{at}umassmed.edu.
 |
REFERENCES |
| 1.
|
Bagai, S., and R. A. Lamb.
1995.
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.
J. Virol.
69:6712-6719[Abstract].
|
| 2.
|
Buckland, R.,
E. Malvoisin,
P. Beauverger, and F. Wild.
1992.
A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion.
J. Gen. Virol.
73:1703-1707[Abstract/Free Full Text].
|
| 3.
|
Buckland, R., and F. Wild.
1989.
Leucine zipper motif extends.
Nature
338:547[Medline].
|
| 4.
|
Chambers, P.,
C. R. Pringle, and J. J. Easton.
1990.
Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.
J. Gen. Virol.
71:3075-3080[Abstract/Free Full Text].
|
| 5.
|
Ghosh, J. K.,
M. Ovadia, and Y. Shai.
1997.
A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus.
Biochemistry
36:15451-15462[CrossRef][Medline].
|
| 6.
|
Ghosh, J. K., and Y. Shai.
1998.
A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion.
J. Biol. Chem.
273:7252-7259[Abstract/Free Full Text].
|
| 7.
|
Hernandez, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Biol.
12:627-661[CrossRef][Medline].
|
| 8.
|
Horvath, C. M.,
R. G. Paterson,
M. A. Shaughnessy,
R. Wood, and R. A. Lamb.
1992.
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.
J. Virol.
66:4564-4569[Abstract/Free Full Text].
|
| 9.
|
Hu, X.,
R. Ray, and R. W. Compans.
1992.
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.
J. Virol.
66:1528-1534[Abstract/Free Full Text].
|
| 10.
|
Ito, M.,
M. Nishio,
M. Kawano,
S. Kusagawa,
H. Komada,
Y. Ito, and M. Tsurudome.
1997.
Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation.
J. Virol.
71:9855-9858[Abstract].
|
| 11.
|
Joshi, S. B.,
R. E. Dutch, and R. A. Lamb.
1998.
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
Virology
248:20-34[CrossRef][Medline].
|
| 12.
|
Karron, R. A.,
D. A. Buonagurio,
A. F. Georgiu,
S. S. Whiteheat,
J. E. Adamus,
M. L. Clements-Mann,
D. O. Harris,
V. B. Randolph,
S. A. Udem,
B. R. Burphy, and M. S. Sidhu.
1997.
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evalutation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
Proc. Natl. Acad. Sci. USA
94:13961-13966[Abstract/Free Full Text].
|
| 13.
|
Lamb, R. A.
1993.
Paramyxovirus fusion: a hypothesis of changes.
Virology
197:1-11[CrossRef][Medline].
|
| 14.
|
Lamb, R. A., and D. Kolakofsky.
1996.
Paramyxoviridae: the viruses and their replication, p. 1177-1206.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
|
| 15.
|
Lambert, D. M.,
S. Barney,
A. L. Lambert,
K. Guthrie,
R. Medinas,
D. E. Davis,
T. Bucy,
J. Erickson,
G. Merutka, and S. R. Petteway.
1996.
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
Proc. Natl. Acad. Sci. USA
93:2186-2191[Abstract/Free Full Text].
|
| 16.
|
McGinnes, L., and T. Morrison.
1995.
Role of individual oligosaccharide chains in the maturation and activities of the HN protein of NDV.
Virology
212:398-410[CrossRef][Medline].
|
| 17.
|
Morrison, T., and A. Portner.
1991.
Structure, function, and intracellular processing of the glycoproteins of Paramyxoviridae, p. 347-375.
In
D. Kingsbury (ed.), The paramyxoviruses. Plenum Press, New York, N.Y.
|
| 18.
|
Morrison, T. G.,
M. E. Peeples, and L. W. McGinnes.
1987.
Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption.
Proc. Natl. Acad. Sci. USA
84:1020-1029[Abstract/Free Full Text].
|
| 19.
|
Morrison, T. G.,
L. Ward, and A. Semerjian.
1985.
Intracellular processing of the Newcastle disease virus fusion glycoprotein.
J. Virol.
53:851-857[Abstract/Free Full Text].
|
| 20.
|
Moscona, A., and R. W. Peluso.
1991.
Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.
J. Virol.
65:2773-2777[Abstract/Free Full Text].
|
| 21.
|
Nishio, M.,
M. Tsurudome,
H. Komada,
M. Kawano,
N. Tabata,
H. Matsumura,
N. Ikemura,
N. Watanabe, and Y. Ito.
1994.
Fusion properties of cells constitutively expressing human parainfluenza virus type 4A haemagglutinin-neuraminidase and fusion glycoproteins.
J. Gen. Virol.
75:3517-3523[Abstract/Free Full Text].
|
| 22.
|
Olmsted, R. A.,
N. Elang,
G. A. Prince,
B. R. Murphy,
P. R. Johnson,
B. Moss,
R. M. Chanock, and P. L. Collins.
1986.
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus; comparison of the individual contributions of the F and G glycoproteins to host immunity.
Proc. Natl. Acad. Sci. USA
83:7462-7466[Abstract/Free Full Text].
|
| 23.
|
Rapaport, D.,
M. Ovadia, and Y. Shai.
1995.
A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.
EMBO J.
14:5524-5531[Medline].
|
| 24.
|
Reitter, J.,
T. Sergel, and T. Morrison.
1995.
Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein.
J. Virol.
69:5995-6004[Abstract].
|
| 25.
|
Sergel, T.,
L. W. McGinnes, and T. G. Morrison.
1993.
The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity.
Virology
196:831-834[CrossRef][Medline].
|
| 26.
|
Sergel, T.,
L. W. McGinnes,
M. E. Peeples, and T. G. Morrison.
1993.
The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.
Virology
193:717-726[CrossRef][Medline].
|
| 27.
|
Sergel-Germano, T.,
C. McQuain, and T. Morrison.
1994.
Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion.
J. Virol.
68:7654-7658[Abstract/Free Full Text].
|
| 28.
|
Tanabayashi, K.,
K. Takeuchi,
K. Okazaki,
M. Hishiyama, and A. Yamada.
1993.
Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for fusion.
Virology
187:801-804.
|
| 29.
|
Taylor, J.,
R. Weinberg,
J. Tartaglia,
C. Richardson,
G. Alkhatib,
D. Breidis,
M. Appel,
E. Norton, and E. Paoletti.
1992.
Nonreplicating viral vectors as potential vaccines: recombinant canary pox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
Virology
187:321-328[CrossRef][Medline].
|
| 30.
|
Wang, C.,
G. Raghu,
T. Morrison, and M. E. Peeples.
1992.
Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain.
J. Virol.
66:4161-4169[Abstract/Free Full Text].
|
| 31.
|
Wild, T. F., and R. Buckland.
1997.
Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein.
J. Gen. Virol.
78:107-111[Abstract].
|
| 32.
|
Yao, Q., and R. W. Compans.
1996.
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
Virology
223:103-112[CrossRef][Medline].
|
| 33.
|
Young, J. K.,
R. P. Hicks,
G. E. Wright, and T. G. Morrison.
1997.
Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.
Virology
238:291-304[CrossRef][Medline].
|
| 34.
|
Young, J. K.,
D. Li,
M. C. Abramowitz, and T. G. Morrison.
1999.
Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.
J. Virol.
73:5945-5956[Abstract/Free Full Text].
|
Journal of Virology, June 2000, p. 5101-5107, Vol. 74, No. 11
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Plattet, P., Cherpillod, P., Wiener, D., Zipperle, L., Vandevelde, M., Wittek, R., Zurbriggen, A.
(2007). Signal Peptide and Helical Bundle Domains of Virulent Canine Distemper Virus Fusion Protein Restrict Fusogenicity. J. Virol.
81: 11413-11425
[Abstract]
[Full Text]
-
Vigil, A., Park, M.-S., Martinez, O., Chua, M. A., Xiao, S., Cros, J. F., Martinez-Sobrido, L., Woo, S. L.C., Garcia-Sastre, A.
(2007). Use of Reverse Genetics to Enhance the Oncolytic Properties of Newcastle Disease Virus. Cancer Res.
67: 8285-8292
[Abstract]
[Full Text]
-
Gardner, A. E., Dutch, R. E.
(2007). A Conserved Region in the F2 Subunit of Paramyxovirus Fusion Proteins Is Involved In Fusion Regulation. J. Virol.
81: 8303-8314
[Abstract]
[Full Text]
-
Luque, L. E., Russell, C. J.
(2007). Spring-Loaded Heptad Repeat Residues Regulate the Expression and Activation of Paramyxovirus Fusion Protein. J. Virol.
81: 3130-3141
[Abstract]
[Full Text]
-
Cantin, C., Holguera, J., Ferreira, L., Villar, E., Munoz-Barroso, I.
(2007). Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J. Gen. Virol.
88: 559-569
[Abstract]
[Full Text]
-
Bousse, T., Takimoto, T.
(2006). Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.. J. Virol.
80: 9009-9016
[Abstract]
[Full Text]
-
Doyle, J., Prussia, A., White, L. K., Sun, A., Liotta, D. C., Snyder, J. P., Compans, R. W., Plemper, R. K.
(2006). Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein. J. Virol.
80: 1524-1536
[Abstract]
[Full Text]
-
Li, J., Melanson, V. R., Mirza, A. M., Iorio, R. M.
(2005). Decreased Dependence on Receptor Recognition for the Fusion Promotion Activity of L289A-Mutated Newcastle Disease Virus Fusion Protein Correlates with a Monoclonal Antibody-Detected Conformational Change. J. Virol.
79: 1180-1190
[Abstract]
[Full Text]
-
Russell, C. J., Jardetzky, T. S., Lamb, R. A.
(2004). Conserved Glycine Residues in the Fusion Peptide of the Paramyxovirus Fusion Protein Regulate Activation of the Native State. J. Virol.
78: 13727-13742
[Abstract]
[Full Text]
-
Ebert, O., Shinozaki, K., Kournioti, C., Park, M.-S., Garcia-Sastre, A., Woo, S. L. C.
(2004). Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer. Cancer Res.
64: 3265-3270
[Abstract]
[Full Text]
-
Huang, Z., Panda, A., Elankumaran, S., Govindarajan, D., Rockemann, D. D., Samal, S. K.
(2004). The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence. J. Virol.
78: 4176-4184
[Abstract]
[Full Text]
-
Russell, C. J., Kantor, K. L., Jardetzky, T. S., Lamb, R. A.
(2003). A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J. Cell Biol.
163: 363-374
[Abstract]
[Full Text]
-
Porotto, M., Murrell, M., Greengard, O., Moscona, A.
(2003). Triggering of Human Parainfluenza Virus 3 Fusion Protein (F) by the Hemagglutinin-Neuraminidase (HN) Protein: an HN Mutation Diminishes the Rate of F Activation and Fusion. J. Virol.
77: 3647-3654
[Abstract]
[Full Text]
-
Seth, S., Vincent, A., Compans, R. W.
(2002). Mutations in the Cytoplasmic Domain of a Paramyxovirus Fusion Glycoprotein Rescue Syncytium Formation and Eliminate the Hemagglutinin-Neuraminidase Protein Requirement for Membrane Fusion. J. Virol.
77: 167-178
[Abstract]
[Full Text]
-
Takimoto, T., Taylor, G. L., Connaris, H. C., Crennell, S. J., Portner, A.
(2002). Role of the Hemagglutinin-Neuraminidase Protein in the Mechanism of Paramyxovirus-Cell Membrane Fusion. J. Virol.
76: 13028-13033
[Abstract]
[Full Text]
-
Yu, M., Wang, E., Liu, Y., Cao, D., Jin, N., Zhang, C. W.-H., Bartlam, M., Rao, Z., Tien, P., Gao, G. F.
(2002). Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus. J. Gen. Virol.
83: 623-629
[Abstract]
[Full Text]
-
Tsurudome, M., Ito, M., Nishio, M., Kawano, M., Komada, H., Ito, Y.
(2001). Hemagglutinin-Neuraminidase-Independent Fusion Activity of Simian Virus 5 Fusion (F) Protein: Difference in Conformation between Fusogenic and Nonfusogenic F Proteins on the Cell Surface. J. Virol.
75: 8999-9009
[Abstract]
[Full Text]